Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · IEX Real-Time Price · USD
6.55
+0.15 (2.34%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Viemed Healthcare Revenue
Viemed Healthcare had revenue of $194.05M in the twelve months ending March 31, 2024, with 32.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $50.59M with 27.90% year-over-year growth. In the year 2023, Viemed Healthcare had annual revenue of $183.01M with 31.82% growth.
Revenue (ttm)
$194.05M
Revenue Growth
+32.79%
P/S Ratio
1.31
Revenue / Employee
$188,393
Employees
1,030
Market Cap
254.28M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 183.01M | 44.18M | 31.82% |
Dec 31, 2022 | 138.83M | 21.77M | 18.60% |
Dec 31, 2021 | 117.06M | -14.25M | -10.85% |
Dec 31, 2020 | 131.31M | 51.05M | 63.61% |
Dec 31, 2019 | 80.26M | 15.79M | 24.50% |
Dec 31, 2018 | 64.46M | 17.54M | 37.37% |
Dec 31, 2017 | 46.93M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Aurora Cannabis | 253.96M |
Sutro Biopharma | 154.07M |
Pulmonx | 72.99M |
CVRx, Inc. | 42.09M |
Mersana Therapeutics | 38.30M |
Adaptimmune Therapeutics | 18.36M |
Molecular Partners AG | 7.64M |
Nyxoah | 5.57M |
VMD News
- 2 months ago - Viemed Healthcare Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Viemed Healthcare Announces Date and Time for Conference Call - GlobeNewsWire
- 3 months ago - Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health - GlobeNewsWire
- 4 months ago - Viemed Healthcare Announces Record 2023 Financial Results - GlobeNewsWire
- 7 months ago - Viemed to Centralize Market for Common Shares on NASDAQ Through Voluntary Delisting from TSX - GlobeNewsWire
- 8 months ago - Viemed Healthcare to Present at Stifel 2023 Healthcare Conference - GlobeNewsWire
- 8 months ago - Viemed Healthcare Announces Record Third Quarter 2023 Financial Results - GlobeNewsWire
- 10 months ago - Viemed Healthcare to Participate in Upcoming Investor Conferences - GlobeNewsWire